Plain-English translation of NCT06659120 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is watching how , a preventive migraine medication, works for women who get migraines linked to their menstrual cycle. Researchers want to understand whether this medication works just as well for period-related migraines as it does for migraines that happen at other times of the month. You would keep a simple daily headache diary to help track this.
Many women find that their migraines are worse around their period, but doctors don't yet know if this medication works equally well for menstrual migraines compared to other types. This study will help answer that question in real-world practice.
You likely qualify if…
You likely don't qualify if…
You would continue keeping a daily headache diary for at least 6 months after starting the medication—recording each day you have a headache, how long it lasts, how severe it is, what medication you take, and when your period occurs. This is part of your regular care, not a special study visit. The study takes place in Switzerland and is run through routine clinical appointments with your doctor.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Switzerland
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment target
~120 participants
Started
April 2024
Primary completion
December 2026
Age range
18 Years and older
Sex
Female only
Last updated on clinicaltrials.gov in October 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Christoph J Schankin, Prof
Inselspital, Department of Neurology, Bern
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.